Atlas Trials

Effect of Rifampicin on the Pharmacokinetics and Pharmacodynamics of Sotagliflozin

Clinical trial NCT03063580 · COMPLETED

Trial details

NCT number
NCT03063580
Sponsor
Sanofi
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
Diabetes Mellitus
Start date
2017-02-27
Primary completion
2017-05-12
Enrollment
16

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.